Hydralazine does not Ameliorate Nitric Oxide Resistance in Chronic Heart Failure

By Chirkov Yuliy   Sciscio Michele   Sverdlov Aaron   Leslie Sue   Sage Peter   Horowitz John  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 2, 2010-04 ,pp. : 131-137

Springer Publishing Company

Access to resources Recommend Favorite

Adenosine therapy: a new approach to chronic heart failure

By Kitakaze M.   Hori M.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2519-2535

Informa Healthcare

Access to resources Recommend Favorite

The Antagonism of Aldosterone Receptor Prevents the Development of Hypertensive Heart Failure Induced by Chronic Inhibition of Nitric Oxide Synthesis in Rats

By Tsukamoto Osamu   Minamino Tetsuo   Sanada Shoji   Okada Ken-ichiro   Hirata Akio   Fujita Masashi   Shintani Yasunori   Yulin Liao   Asano Yoshihiro   Takashima Seiji   Yamasaki Satoru   Tomoike Hitonobu   Hori Masatsugu   Kitakaze Masafumi  

Cardiovascular Drugs and Therapy, Vol. 20, Iss. 2, 2006-04 ,pp. : 93-102

Springer Publishing Company

Access to resources Recommend Favorite

Carvedilol in the treatment of chronic heart failure

By Moe G.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 5, 2001-05 ,pp. : 831-843

Informa Healthcare

Access to resources Recommend Favorite

Dopamine-independent and adenosine-dependent mechanisms involved in the effects of N-methyl-d-aspartate on motor activity in mice

By Gimenez-Llort L.   Martinez E.   Ferre S.  

European Journal of Pharmacology, Vol. 275, Iss. 2, 1995-03 ,pp. : 171-177

Elsevier

Access to resources Recommend Favorite